Guido Frosina
Overview
Explore the profile of Guido Frosina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
639
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Frosina G, Casella C, Puppo A, Marani E, Campanella D, Boni L, et al.
Sci Rep
. 2024 Nov;
14(1):27300.
PMID: 39516674
We present an updated analysis on the incidence of primary brain tumors in the Metropolitan Area of Genova, the capital of the northwestern Italian region Liguria.The number of cases and...
3.
4.
Frosina G
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672647
The first half of 2022 saw the publication of several major research advances in image-based models and artificial intelligence applications to optimize treatment strategies for high-grade gliomas, the deadliest brain...
5.
Frosina G
Crit Rev Oncol Hematol
. 2023 Sep;
190:104110.
PMID: 37657520
This article discusses the studies on radiotherapy of high-grade gliomas published between January 1, 2022, and June 30, 2022, with special reference to their molecular biology basis. The focus was...
6.
Frosina G
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047356
High-grade gliomas (World Health Organization grades III and IV) are the most frequent and fatal brain tumors, with median overall survivals of 24-72 and 14-16 months, respectively. We reviewed the...
7.
Frosina G
Strahlenther Onkol
. 2022 Nov;
199(1):1-21.
PMID: 36445383
Purpose: This review article discusses the studies concerning advances in radiotherapy of high-grade gliomas published in the second half of 2021. Methods: A literature search was performed in PubMed using...
8.
Frosina G
J Neurosci Res
. 2022 Feb;
100(4):933-946.
PMID: 35184314
Ionizing radiation is a mainstay of high-grade glioma therapy. The current standard radiotherapeutic schedule involves a total 60 Gy split in 2.0 Gy fractions delivered on weekdays for six weeks....
9.
Frosina G, Fontana V, Verzola D, Rosa A, Gaggero G, Garibotto G, et al.
J Neurosci Res
. 2021 Nov;
99(12):3182-3203.
PMID: 34747065
High-grade gliomas (HGGs; WHO grades III and IV) are invariably lethal brain tumors. Low-dose hyper-radiosensitivity (HRS) of HGG is a well-established phenomenon in vitro. However, possibly linked to the unavailability...
10.
Frosina G
Int J Mol Sci
. 2021 Aug;
22(16).
PMID: 34445646
Albeit the effort to develop targeted therapies for patients with high-grade gliomas (WHO grades III and IV) is evidenced by hundreds of current clinical trials, radiation remains one of the...